AI assistant
GlaxoSmithKline PLC AGM Information 2024
5262_agm-r_2024-05-08_5231d9f0-d033-4b1f-9f5c-d2a65923af6b.html
AGM Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 6940N
GSK PLC
08 May 2024
GSK plc
Results of 24th Annual General Meeting
GSK plc ('GSK') held a hybrid Annual General Meeting ('AGM') at 2.30pm on Wednesday 8 May 2024 at the Royal Lancaster London, Lancaster Terrace, London, W2 2TY. Shareholders were able to join the meeting in person or virtually via the Lumi AGM website.
All valid proxy votes (whether submitted electronically or in hard copy form) were included in the poll taken at the meeting.
The table below shows the results of the poll on all 23 resolutions. The full text of the resolutions is contained in the Notice of AGM published on 25 March 2024, which is available on GSK's website at www.gsk.com .
| Resolution | Total votes for (1)(2) | % | Total votes against (2) | % | Total votes cast | Votes withheld (3) | |
|---|---|---|---|---|---|---|---|
| 1 | Receive and adopt the 2023 Annual Report | 3,026,657,634 | 99.93 | 1,985,899 | 0.07 | 3,028,643,533 | 11,560,313 |
| 2 | Approve the Annual report on remuneration | 2,782,337,600 | 92.70 | 219,140,461 | 7.30 | 3,001,478,061 | 38,693,019 |
| 3 | Election of Wendy Becker | 2,908,153,080 | 95.87 | 125,392,399 | 4.13 | 3,033,545,479 | 6,609,293 |
| 4 | Election od Dr Jeannie Lee | 3,029,569,885 | 99.87 | 4,058,143 | 0.13 | 3,033,628,028 | 6,567,803 |
| 5 | Re-election of Sir Jonathan Symonds | 3,018,694,064 | 99.51 | 14,982,162 | 0.49 | 3,033,676,226 | 6,516,614 |
| 6 | Re-election of Dame Emma Walmsley | 3,028,232,685 | 99.81 | 5,822,706 | 0.19 | 3,034,055,391 | 6,142,099 |
| 7 | Re-election of Julie Brown | 3,024,167,039 | 99.68 | 9,628,961 | 0.32 | 3,033,796,000 | 6,386,918 |
| 8 | Re-election of Elizabeth McKee Anderson | 2,960,185,482 | 97.57 | 73,605,787 | 2.43 | 3,033,791,269 | 6,404,117 |
| 9 | Re-election of Charles Bancroft | 3,019,529,985 | 99.54 | 13,986,857 | 0.46 | 3,033,516,842 | 6,668,927 |
| 10 | Re-election of Dr Hal Barron | 3,022,032,114 | 99.61 | 11,790,927 | 0.39 | 3,033,823,041 | 6,360,307 |
| 11 | Re-election of Dr Anne Beal | 3,021,808,961 | 99.60 | 12,038,342 | 0.40 | 3,033,847,303 | 6,336,638 |
| 12 | Re-election of Dr Harry C Dietz | 3,029,031,724 | 99.85 | 4,650,326 | 0.15 | 3,033,682,050 | 6,508,974 |
| 13 | Re-election of Dr Jesse Goodman | 3,028,663,561 | 99.84 | 4,930,361 | 0.16 | 3,033,593,922 | 6,598,956 |
| 14 | Re-election of Dr Vishal Sikka | 2,868,354,507 | 94.57 | 164,801,089 | 5.43 | 3,033,155,596 | 7,017,053 |
| 15 | Re-appointment of the auditor | 3,014,623,759 | 99.95 | 1,608,077 | 0.05 | 3,016,231,836 | 23,950,717 |
| 16 | Remuneration of the auditor | 3,031,902,105 | 99.92 | 2,552,472 | 0.08 | 3,034,454,577 | 5,710,703 |
| 17 | Authority for the company to make donations to political organisations and incur political expenditure | 2,932,886,023 | 98.76 | 36,920,830 | 1.24 | 2,969,806,853 | 70,418,813 |
| 18 | Authority to allot shares | 2,902,088,897 | 95.68 | 130,945,918 | 4.32 | 3,033,034,815 | 7,163,455 |
| 19 | Disapplication of pre-emption rights - general power (4) | 2,961,493,840 | 97.71 | 69,555,193 | 2.29 | 3,031,049,033 | 9,105,429 |
| 20 | Disapplication of pre-emption rights - in connection with an acquisition or specified capital investment (4) | 2,937,510,909 | 96.91 | 93,802,022 | 3.09 | 3,031,312,931 | 8,843,231 |
| 21 | Authority for the company to purchase its own shares (4) | 3,007,905,874 | 99.25 | 22,735,155 | 0.75 | 3,030,641,029 | 9,526,430 |
| 22 | Exemption from statement of senior statutory auditor's name | 2,960,435,195 | 99.72 | 8,381,561 | 0.28 | 2,968,816,756 | 71,372,939 |
| 23 | Authority for reduced notice of a general meeting other than an AGM (4) | 2,795,236,350 | 93.79 | 185,233,215 | 6.21 | 2,980,469,565 | 59,729,307 |
Notes:
(1) The "for" votes include those giving the Chair discretion.
(2) Votes "for" and "against" are expressed as a percentage of the total votes cast.
(3) A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of votes "for" or "against" a resolution.
(4) Indicates Special Resolutions requiring a 75% majority of votes cast.
The Company's issued share capital as at 3 May 2024 consisted of 4,144,937,355 shares of 31 ¼ pence each ('Ordinary Shares') excluding Ordinary Shares held in Treasury. Every shareholder has one vote for every Ordinary Share held.
The above poll results will shortly be available on the company's website at www.gsk.com .
In accordance with Listing Rule 9.6.2 of the Financial Conduct Authority's (FCA) Listing Rules, a copy of the resolutions, other than those concerning ordinary business, will be submitted to the FCA and will in due course be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
V A Whyte
Company Secretary
8 May 2024
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGAPMRTMTTMBMI